API
< Back to all clusters
[HEALTH] · Ghana · 2 sources

started · updated

Ghana targets local medicine production to address HIV funding gap

Ghana is pursuing a new national pharmaceutical policy to double the domestic production of medicines from 30% to 60% within five years. Launched by Trade, Agribusiness and Industry Minister Elizabeth Ofosu-Adjare, the policy aims to reduce the country's reliance on imports and lower the estimated $14 billion annual foreign exchange bill incurred by Ghana and neighboring African nations for pharmaceutical imports.

The initiative comes as the Ghana AIDS Commission reports a significant funding shortfall for HIV prevention. John Eliasu Mahama, Acting Director of Policy and Planning at the commission, stated that Ghana requires approximately $25.7 million annually for HIV prevention, yet domestic spending in this category was only about $400,000 in 2024.

To mitigate these financial gaps and reduce dependence on foreign donors, officials are exploring the local manufacturing of antiretroviral drugs. The National Pharmaceutical Manufacturing Policy seeks to attract investment, expand capacity, and address challenges such as the high cost of imported raw materials and limited technology transfer.

Entities

Elizabeth Ofosu-Adjare · Ghana · Ghana AIDS Commission · John Eliasu Mahama